Reduction of Serum Cholesterol and Triglyceride Levels by the Combined Administration of Neomycin and Clofibrate
Circulation - United States
doi 10.1161/01.cir.41.1.109
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 1970
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)